Cardiovascular Magnetic Resonance Imaging
暂无分享,去创建一个
[1] Ralph Weissleder,et al. Seeing Within: Molecular Imaging of the Cardiovascular System , 2004, Circulation research.
[2] R. Kim,et al. Rapid Detection of Myocardial Infarction by Subsecond, Free-Breathing Delayed Contrast-Enhancement Cardiovascular Magnetic Resonance , 2006, Circulation.
[3] Katherine C. Wu,et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. , 2005, The New England journal of medicine.
[4] Peter Boesiger,et al. Improved three‐dimensional free‐breathing coronary magnetic resonance angiography using gadocoletic acid (B‐22956) for intravascular contrast enhancement , 2004, Journal of magnetic resonance imaging : JMRI.
[5] D. Pennell,et al. Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. , 2006, Journal of the American College of Cardiology.
[6] René M. Botnar,et al. Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience. , 2007, Radiology.
[7] A. Tajik,et al. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. , 2007, Journal of the American College of Cardiology.
[8] E. McVeigh,et al. Phase‐sensitive inversion recovery for detecting myocardial infarction using gadolinium‐delayed hyperenhancement † , 2002, Magnetic resonance in medicine.
[9] J. Carr,et al. Prediction of cardiac events in patients with reduced left ventricular ejection fraction with dobutamine cardiovascular magnetic resonance assessment of wall motion score index. , 2008, Journal of the American College of Cardiology.
[10] W. Manning,et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. , 2008, Journal of the American College of Cardiology.
[11] M. Robson,et al. Cardiovascular magnetic resonance perfusion imaging at 3-tesla for the detection of coronary artery disease: a comparison with 1.5-tesla. , 2007, Journal of the American College of Cardiology.
[12] H. Halperin,et al. Clinical Utility and Safety of a Protocol for Noncardiac and Cardiac Magnetic Resonance Imaging of Patients With Permanent Pacemakers and Implantable-Cardioverter Defibrillators at 1.5 Tesla , 2006, Circulation.
[13] F. Van de Werf,et al. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. , 2009, European heart journal.
[14] O. Simonetti,et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.
[15] J. Lima,et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. , 2005, Journal of the American College of Cardiology.
[16] R. Kim,et al. Visualization of Discrete Microinfarction After Percutaneous Coronary Intervention Associated With Mild Creatine Kinase-MB Elevation , 2001, Circulation.
[17] Daniel F. Kacher,et al. Characterization of Human Atherosclerotic Plaques by Intravascular Magnetic Resonance Imaging , 2005, Circulation.
[18] Mark A Westwood,et al. Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. , 2006, Haematologica.
[19] P. Kellman,et al. Quantitative myocardial infarction on delayed enhancement MRI. Part I: Animal validation of an automated feature analysis and combined thresholding infarct sizing algorithm , 2006, Journal of magnetic resonance imaging : JMRI.
[20] Roger B. Davis,et al. Impact of Unrecognized Myocardial Scar Detected by Cardiac Magnetic Resonance Imaging on Event-Free Survival in Patients Presenting With Signs or Symptoms of Coronary Artery Disease , 2006, Circulation.
[21] J. Grizzard. Magnetic resonance imaging of pericardial disease and intracardiac thrombus. , 2009, Heart failure clinics.
[22] Benjamin D. Levine,et al. Cardiac Steatosis in Diabetes Mellitus: A 1H-Magnetic Resonance Spectroscopy Study , 2007, Circulation.
[23] K. Durongpisitkul,et al. Predictors of Successful Transcatheter Closure of Atrial Septal Defect by Cardiac Magnetic Resonance Imaging , 2004, Pediatric Cardiology.
[24] R. Kwong,et al. Complementary Prognostic Values of Stress Myocardial Perfusion and Late Gadolinium Enhancement Imaging by Cardiac Magnetic Resonance in Patients With Known or Suspected Coronary Artery Disease , 2009, Circulation.
[25] J. Felblinger,et al. Detection of myocarditis by contrast‐enhanced MRI in patients presenting with acute coronary syndrome but no coronary stenosis , 2007, Journal of magnetic resonance imaging : JMRI.
[26] D. Pennell,et al. A Randomized, Placebo-Controlled, Double-Blind Trial of the Effect of Combined Therapy With Deferoxamine and Deferiprone on Myocardial Iron in Thalassemia Major Using Cardiovascular Magnetic Resonance , 2007, Circulation.
[27] M. Robson,et al. Evidence for Microvascular Dysfunction in Hypertrophic Cardiomyopathy: New Insights From Multiparametric Magnetic Resonance Imaging , 2007, Circulation.
[28] Luigi Rega,et al. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2008, Journal of the American College of Cardiology.
[29] M. Horn. Cardiac magnetic resonance spectroscopy: a window for studying physiology. , 2006, Methods in molecular medicine.
[30] Katja Zeppenfeld,et al. Infarct Tissue Heterogeneity Assessed With Contrast-Enhanced MRI Predicts Spontaneous Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and Implantable Cardioverter-Defibrillator , 2009, Circulation. Cardiovascular imaging.
[31] Sebastian Kelle,et al. Prognostic Value of Cardiac Magnetic Resonance Stress Tests: Adenosine Stress Perfusion and Dobutamine Stress Wall Motion Imaging , 2007, Circulation.
[32] R. Kim,et al. Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance. , 2009, Heart failure clinics.
[33] René M. Botnar,et al. In Vivo Magnetic Resonance Imaging of Coronary Thrombosis Using a Fibrin-Binding Molecular Magnetic Resonance Contrast Agent , 2004, Circulation.
[34] Katherine C. Wu,et al. Infarct Tissue Heterogeneity by Magnetic Resonance Imaging Identifies Enhanced Cardiac Arrhythmia Susceptibility in Patients With Left Ventricular Dysfunction , 2007, Circulation.
[35] Hugh Calkins,et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.
[36] R. Kim,et al. Fundamental concepts in myocardial viability assessment revisited: when knowing how much is “alive” is not enough , 2004, Heart.
[37] R. Kim,et al. Performance of Delayed-Enhancement Magnetic Resonance Imaging With Gadoversetamide Contrast for the Detection and Assessment of Myocardial Infarction: An International, Multicenter, Double-Blinded, Randomized Trial , 2008, Circulation.
[38] Matthew W. Darlison,et al. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[39] D. Pennell. MRI and iron-overload cardiomyopathy in thalassaemia. , 2006, Circulation.
[40] D. Kraitchman,et al. Stem cell therapy: MRI guidance and monitoring , 2008, Journal of magnetic resonance imaging : JMRI.
[41] J. Gillard,et al. Identifying Inflamed Carotid Plaques Using In Vivo USPIO-Enhanced MR Imaging to Label Plaque Macrophages , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[42] E. McVeigh,et al. T2‐prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo , 2007, Magnetic resonance in medicine.
[43] Stefan Neubauer,et al. Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations , 2009, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[44] Petros Syrris,et al. Clinical and Genetic Characterization of Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Provides Novel Insights Into Patterns of Disease Expression , 2007, Circulation.
[45] C. Claussen,et al. Risk stratification by adenosine stress cardiac magnetic resonance in patients with coronary artery stenoses of intermediate angiographic severity. , 2009, JACC. Cardiovascular imaging.
[46] R. F. Hoyt,et al. Cardiac magnetic resonance imaging , 2004, Postgraduate Medical Journal.
[47] Diego R Martin,et al. Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities. , 2008, Radiology.
[48] Matthias Stuber,et al. Volume‐targeted and whole‐heart coronary magnetic resonance angiography using an intravascular contrast agent , 2009, Journal of magnetic resonance imaging : JMRI.
[49] Stefan Neubauer,et al. Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance. , 2004, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[50] H. Calkins,et al. Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. , 2006, Journal of the American College of Cardiology.
[51] D. Pennell,et al. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. , 2007, European heart journal.
[52] D. Pennell. T2* Magnetic Resonance and Myocardial Iron in Thalassemia , 2005, Annals of the New York Academy of Sciences.
[53] Chun Yuan,et al. MRI of atherosclerosis , 2004, Journal of magnetic resonance imaging : JMRI.
[54] Matthias Gutberlet,et al. Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .
[55] E. Nagel,et al. Use of Cardiovascular Magnetic Resonance Imaging in Acute Coronary Syndromes , 2009, Circulation.
[56] O. Vignaux,et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. , 2002, Chest.
[57] Fei Liu,et al. MRI of atherosclerosis in clinical trials , 2006, NMR in biomedicine.
[58] Robert G. Weiss,et al. Magnetic Resonance Assessment of the Substrate for Inducible Ventricular Tachycardia in Nonischemic Cardiomyopathy , 2005, Circulation.
[59] W. Stevenson,et al. Characterization of the Peri-Infarct Zone by Contrast-Enhanced Cardiac Magnetic Resonance Imaging Is a Powerful Predictor of Post–Myocardial Infarction Mortality , 2006, Circulation.
[60] E P Walsh,et al. Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair , 2006, Heart.
[61] René M. Botnar,et al. Molecular Magnetic Resonance Imaging of Myocardial Perfusion With EP-3600, a Collagen-Specific Contrast Agent: Initial Feasibility Study in a Swine Model , 2009, Circulation.
[62] E. Nagel,et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[63] R. Muthupillai,et al. Prognostic Significance of Delayed-Enhancement Magnetic Resonance Imaging: Survival of 857 Patients With and Without Left Ventricular Dysfunction , 2009, Circulation.
[64] Manesh R. Patel,et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging. A report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group. , 2006, Journal of the American College of Radiology : JACR.
[65] W. Manning,et al. Coronary magnetic resonance imaging. , 2007, Cardiology clinics.
[66] C. Hamm,et al. Immunohistological basis of the late gadolinium enhancement phenomenon in tako-tsubo cardiomyopathy. , 2009, European heart journal.
[67] E. Fleck,et al. Additional Value of Myocardial Perfusion Imaging During Dobutamine Stress Magnetic Resonance for the Assessment of Coronary Artery Disease , 2008, Circulation. Cardiovascular imaging.
[68] Debiao Li,et al. Contrast-enhanced whole-heart coronary magnetic resonance angiography at 3.0-T: a comparative study with X-ray angiography in a single center. , 2009, Journal of the American College of Cardiology.
[69] S. Sen-Chowdhry,et al. The utility of magnetic resonance imaging in the evaluation of arrhythmogenic right ventricular cardiomyopathy , 2008, Current opinion in cardiology.
[70] D. Pennell,et al. Cardiovascular Magnetic Resonance and prognosis in cardiac amyloidosis , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[71] Daniel C. Lee,et al. Magnetic Resonance Versus Radionuclide Pharmacological Stress Perfusion Imaging for Flow-Limiting Stenoses of Varying Severity , 2004, Circulation.
[72] Eckart Fleck,et al. Magnetic Resonance Low-Dose Dobutamine Test Is Superior to Scar Quantification for the Prediction of Functional Recovery , 2004, Circulation.
[73] S. Priori,et al. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[74] P. Poole‐Wilson,et al. Cardiovascular Magnetic Resonance in Cardiac Amyloidosis , 2005, Circulation.
[75] Stefan Neubauer,et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.
[76] Igor Klem,et al. mproved Detection of Coronary rtery Disease by Stress Perfusion ardiovascular Magnetic Resonance With he Use of Delayed Enhancement Infarction Imaging , 2006 .
[77] John P Ridgway,et al. Coronary artery disease: assessment with a comprehensive MR imaging protocol--initial results. , 2002, Radiology.
[78] Hugh Calkins,et al. A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. , 2008, The New England journal of medicine.
[79] R. Cury,et al. Cardiac Magnetic Resonance With T2-Weighted Imaging Improves Detection of Patients With Acute Coronary Syndrome in the Emergency Department , 2008, Circulation.
[80] R. Kim,et al. Detection of Myocardial Damage in Patients With Sarcoidosis , 2009, Circulation.
[81] N. Geller,et al. Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. , 2006, Journal of the American College of Cardiology.
[82] Peter Kellman,et al. ACUT2E TSE‐SSFP: A hybrid method for T2‐weighted imaging of edema in the heart , 2008, Magnetic resonance in medicine.
[83] Fabien Hyafil,et al. Differentiating acute myocardial infarction from myocarditis: diagnostic value of early- and delayed-perfusion cardiac MR imaging. , 2005, Radiology.
[84] Jürgen Hennig,et al. Three‐dimensional analysis of segmental wall shear stress in the aorta by flow‐sensitive four‐dimensional‐MRI , 2009, Journal of magnetic resonance imaging : JMRI.
[85] René M. Botnar,et al. In Vivo Molecular Imaging of Acute and Subacute Thrombosis Using a Fibrin-Binding Magnetic Resonance Imaging Contrast Agent , 2004, Circulation.
[86] Idith Haber,et al. Effects of Regional Dysfunction and Late Gadolinium Enhancement on Global Right Ventricular Function and Exercise Capacity in Patients With Repaired Tetralogy of Fallot , 2009, Circulation.
[87] Thomas D. Coates,et al. Cardiac Iron Determines Cardiac T2*, T2, and T1 in the Gerbil Model of Iron Cardiomyopathy , 2005, Circulation.
[88] R. Kwong,et al. Incidence and Prognostic Implication of Unrecognized Myocardial Scar Characterized by Cardiac Magnetic Resonance in Diabetic Patients Without Clinical Evidence of Myocardial Infarction , 2008, Circulation.
[89] Martin R Prince,et al. Incidence of nephrogenic systemic fibrosis at two large medical centers. , 2008, Radiology.
[90] Jeroen J. Bax,et al. Feasibility of tissue magnetic resonance imaging: a pilot study in comparison with tissue Doppler imaging and invasive measurement. , 2005, Journal of the American College of Cardiology.
[91] M. Friedrich,et al. Abnormalities in T2‐weighted cardiovascular magnetic resonance images of hypertrophic cardiomyopathy: Regional distribution and relation to late gadolinium enhancement and severity of hypertrophy , 2008, Journal of magnetic resonance imaging : JMRI.
[92] A. van Rossum,et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. , 2008, European heart journal.
[93] E. Fleck,et al. High-dose dobutamine-atropine stress cardiovascular MR imaging after coronary revascularization in patients with wall motion abnormalities at rest. , 2004, Radiology.
[94] R. Kim,et al. Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction. , 2008, Journal of the American College of Cardiology.
[95] Scott D Flamm,et al. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. , 2009, JACC. Cardiovascular imaging.
[96] H. Calkins,et al. Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[97] René M. Botnar,et al. Molecular Magnetic Resonance Imaging of Coronary Thrombosis and Pulmonary Emboli With a Novel Fibrin-Targeted Contrast Agent , 2005, Circulation.
[98] J. Schulz-Menger,et al. Delayed Enhancement and T2-Weighted Cardiovascular Magnetic Resonance Imaging Differentiate Acute From Chronic Myocardial Infarction , 2004, Circulation.
[99] Saman Nazarian,et al. How to perform magnetic resonance imaging on patients with implantable cardiac arrhythmia devices. , 2009, Heart rhythm.
[100] Michael Jerosch-Herold,et al. Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy , 2005, Circulation.
[101] W. Hundley,et al. Dobutamine cardiac magnetic resonance results predict cardiac prognosis in women with known or suspected ischemic heart disease. , 2009, JACC. Cardiovascular imaging.
[102] J. Schulz-Menger,et al. Long-term follow-up of patients with acute myocarditis by magnetic resonance imaging , 2003, Magnetic Resonance Materials in Physics, Biology and Medicine.
[103] Dudley J Pennell,et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.
[104] Mark Doyle,et al. Routine evaluation of left ventricular diastolic function by cardiovascular magnetic resonance: A practical approach , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[105] K. Nayak,et al. Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[106] Horst Olschewski,et al. Magnetic Resonance–Derived 3-Dimensional Blood Flow Patterns in the Main Pulmonary Artery as a Marker of Pulmonary Hypertension and a Measure of Elevated Mean Pulmonary Arterial Pressure , 2008, Circulation. Cardiovascular imaging.
[107] Chun Yuan,et al. Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. , 2006, Radiology.